Form 4: Glaukos CDO Sells Shares Under Pre-Arranged 10b5-1 Plan

Glaukos' Chief Development Officer, Tomas Navratil, sold 5,142 shares of common stock on September 11, 2025, through a pre-arranged 10b5-1 trading plan.

Summary

• Tomas Navratil, Chief Development Officer of Glaukos Corp (GKOS), executed sales of common stock.
• The transactions occurred on September 11, 2025.
• A total of 5,142 shares of common stock were sold in two separate transactions.
• The first sale involved 3,194 shares at a weighted average price of $87.98 per share, with trades ranging from $87.43 to $88.43.
• The second sale involved 1,948 shares at a weighted average price of $88.61 per share, with trades ranging from $88.44 to $88.88.
• These sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Navratil on June 12, 2025.
• Following these transactions, Mr. Navratil beneficially owns 75,469 shares of common stock, which includes 42,589 restricted stock units that have not yet vested or been delivered.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan, which is generally considered a neutral event as it reflects planned liquidity or diversification rather than a reaction to new company-specific news or a change in outlook.

Positives

• Sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned disposition for liquidity or diversification rather than an immediate reaction to new negative company information.

Negatives

• Chief Development Officer Tomas Navratil reduced his direct beneficial ownership of common stock by 5,142 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which is generally viewed neutrally when conducted under a 10b5-1 plan, as it is a pre-planned event for executive liquidity or diversification.

Key Dates

Recommendation

The filing details a pre-scheduled insider stock sale under a 10b5-1 plan, which is a routine event for executive compensation and liquidity management. It does not provide new fundamental information about the company's performance or outlook that would warrant a change in investment thesis. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Glaukos, GKOS, insider trading, Form 4, stock sale, 10b5-1 plan, Tomas Navratil, Chief Development Officer, equity disposition